Unbound MEDLINE

Fentanyl effervescent buccal tablets: new formulation. For cancer patients with breakthrough pain: a second buccal formulation with minimal evaluation. [Prescrire Int] Journal article

 
Fentanyl effervescent buccal tablets: new formulation. For cancer patients with breakthrough pain: a second buccal formulation with minimal evaluation. [Journal Article]
Prescrire Int 2009 Oct; 18(103):205.


There is no firm evidence that patients with breakthrough cancer pain respond better to fentanyl effervescent buccal than to the "lollipop" formulation.


More from this journal
  
Advertise on this site.